Fred Alger Management’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-61,572
Closed -$1.48M 443
2025
Q1
$1.48M Sell
61,572
-42,995
-41% -$1.52M 0.01% 312
2024
Q4
$3.91M Buy
104,567
+46,425
+80% +$2.17M 0.02% 267
2024
Q3
$2.91M Buy
58,142
+17,848
+44% +$694K 0.01% 297
2024
Q2
$1.4M Sell
40,294
-10,810
-21% -$427K 0.01% 344
2024
Q1
$2.79M Sell
51,104
-15,860
-24% -$785K 0.01% 313
2023
Q4
$2.87M Sell
66,964
-3,757
-5% -$117K 0.02% 298
2023
Q3
$1.84M Sell
70,721
-44,951
-39% -$934K 0.01% 329
2023
Q2
$2.77M Sell
115,672
-52,175
-31% -$898K 0.01% 303
2023
Q1
$2.29M Sell
167,847
-33,441
-17% -$532K 0.01% 328
2022
Q4
$2.79M Buy
+201,288
New +$2.84M 0.02% 309

Other funds holding BHVN

Fred Alger Management's BHVN Position: Q2 2025 in Review

Fred Alger Management sold out of Biohaven (BHVN) in Q2 2025, closing a stake of 61,572 shares — an estimated $1.48M sold.

Fred Alger Management first reported a position in BHVN in Q4 2022 and held it in 10 quarters. The position peaked at $3.91M in Q4 2024. 249 funds tracked by Wall St. Rank hold BHVN as of Q2 2025.

  • Fred Alger Management reported no remaining Biohaven position as of Q2 2025 after selling out during the quarter.
  • Fred Alger Management sold 61,572 Biohaven shares in Q2 2025, an estimated $1.48M.
  • Fred Alger Management first reported a position in Biohaven in Q4 2022 and held it in 10 quarters.
  • Fred Alger Management's Biohaven position peaked at $3.91M in Q4 2024.
  • 249 funds tracked by Wall St. Rank held Biohaven as of Q2 2025.

Based on Fred Alger Management's 13F filing for Q2 2025, filed 14 Aug 2025.